Connect
MJA
MJA

Opioid overdose deaths can occur in patients with naltrexone implants

Robert G Batey
Med J Aust 2007; 187 (1): 55.

To the Editor: Gibson and colleagues recently reported opioid overdose deaths occurring in patients with naltrexone implants.1 The article is of great clinical significance, identifying that patients can override the effect of naltrexone and experience fatal opioid toxicity. However, it fails to address some important clinical and forensic issues that the five deaths highlight.

Please login with your free MJA account to view this article in full

  • Robert G Batey

  • University of New South Wales, Sydney, NSW.


  • 1. Gibson AE, Degenhardt LJ, Hall WD. Opioid overdose deaths can occur in patients with naltrexone implants. Med J Aust 2007; 186: 152-153. <MJA full text>
  • 2. Digiusto E, Shakeshaft A, Ritter A, et al. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Addiction 2004; 99: 450-460.
  • 3. Sullivan MA, Comer SD, Nunes EV. Pharmacology and clinical use of naltrexone. In: Strain EC, Stitzer ML, editors. The treatment of opioid dependence. Baltimore: Johns Hopkins University Press, 2006: 295-320.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.